BioLife Solutions, Inc. Debt Securities, Available-for-sale, Amortized Cost, Noncurrent
BioLife Solutions, Inc. (BLFS) had Debt Securities, Available-for-sale, Amortized Cost, Noncurrent of $30.79 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Credit Losses › Debt Securities, Available-for-Sale, Amortized Cost
us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent · last filed 2026-08-06
- 2026-06-30: Debt Securities, Available-for-sale, Amortized Cost, Noncurrent $30.79M.
- 2026-03-31: Debt Securities, Available-for-sale, Amortized Cost, Noncurrent $30.60M.
- 2025-12-31: Debt Securities, Available-for-sale, Amortized Cost, Noncurrent $31.21M.
- 2025-09-30: Debt Securities, Available-for-sale, Amortized Cost, Noncurrent $19.40M.
| Period end | Debt Securities, Available-for-sale, Amortized Cost, Noncurrent |
|---|---|
| 2026-06-30 | $30.79M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $30.60M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $31.21M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $19.40M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $18.43M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $19.04M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $4.62M 10-K · filed 2026-02-26 |
| 2024-09-30 | $4.85M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $2.69M 10-Q · filed 2024-08-09 |
| 2024-03-31 | $823.00K 10-Q · filed 2024-05-10 |
| 2023-12-31 | $545.00K 10-K · filed 2024-02-29 |
| 2023-09-30 | $1.16M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $1.84M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $2.02M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $1.33M 10-K · filed 2023-03-31 |
| 2022-09-30 | $490.00K 10-Q · filed 2022-11-09 |
| 2022-06-30 | $491.00K 10-Q · filed 2022-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B |